Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PALBOCICLIB vs PALIVIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PALBOCICLIB vs PALIVIZUMAB: Safety Overview

Metric PALBOCICLIB PALIVIZUMAB
Total FAERS Reports 91,024 11,419
Deaths Reported 11,066 1,248
Death Rate 12.2% 10.9%
Hospitalizations 13,442 6,461
Average Patient Age 66.0 yrs 0.8 yrs
% Female Patients 97.7% 42.2%
FDA Approval Date Feb 3, 2015 N/A
Manufacturer Pfizer Laboratories Div Pfizer Inc Swedish Orphan Biovitrum AB (publ)
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Prescription